CRYO-CELL INTL INC (CCEL) Stock Fundamental Analysis
NYSEARCA:CCEL - NYSE Arca - US2288951088 - Common Stock - Currency: USD
Overall CCEL gets a fundamental rating of 4 out of 10. We evaluated CCEL against 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CCEL while its profitability can be described as average. CCEL is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CCEL had positive earnings in the past year.
In the past year CCEL had a positive cash flow from operations.
CCEL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.20%, CCEL is in line with its industry, outperforming 48.54% of the companies in the same industry.
CCEL's Return On Invested Capital of 7.45% is fine compared to the rest of the industry. CCEL outperforms 71.84% of its industry peers.
CCEL had an Average Return On Invested Capital over the past 3 years of 7.61%. This is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.2% | ||
| ROE | N/A | ||
| ROIC | 7.45% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
With a Profit Margin value of 0.40%, CCEL perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
CCEL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.53%, CCEL belongs to the top of the industry, outperforming 83.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CCEL has declined.
The Gross Margin of CCEL (75.79%) is better than 89.32% of its industry peers.
CCEL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.53% | ||
| PM (TTM) | 0.4% | ||
| GM | 75.79% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCEL is destroying value.
Compared to 1 year ago, CCEL has less shares outstanding
CCEL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCEL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.10, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CCEL (0.10) is worse than 77.67% of its industry peers.
CCEL has a debt to FCF ratio of 1.59. This is a very positive value and a sign of high solvency as it would only need 1.59 years to pay back of all of its debts.
The Debt to FCF ratio of CCEL (1.59) is better than 84.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.59 | ||
| Altman-Z | 0.1 |
ROIC/WACC0.7
WACC10.6%
2.3 Liquidity
A Current Ratio of 0.58 indicates that CCEL may have some problems paying its short term obligations.
CCEL's Current ratio of 0.58 is on the low side compared to the rest of the industry. CCEL is outperformed by 88.35% of its industry peers.
A Quick Ratio of 0.54 indicates that CCEL may have some problems paying its short term obligations.
CCEL has a Quick ratio of 0.54. This is amonst the worse of the industry: CCEL underperforms 85.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
CCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.72%, which is quite impressive.
CCEL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -29.04% yearly.
Looking at the last year, CCEL shows a small growth in Revenue. The Revenue has grown by 2.33% in the last year.
CCEL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.11% yearly.
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%
3.2 Future
Based on estimates for the next years, CCEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -68.82% on average per year.
CCEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.77% yearly.
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 259.50, the valuation of CCEL can be described as expensive.
Based on the Price/Earnings ratio, CCEL is valued a bit more expensive than 60.19% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.15. CCEL is valued rather expensively when compared to this.
CCEL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 259.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
72.82% of the companies in the same industry are more expensive than CCEL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 90.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.89 | ||
| EV/EBITDA | 8.95 |
4.3 Compensation for Growth
CCEL's earnings are expected to decrease with -68.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.82%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 15.97%, CCEL is a good candidate for dividend investing.
CCEL's Dividend Yield is rather good when compared to the industry average which is at 2.37. CCEL pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 15.97% |
5.2 History
CCEL has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
CCEL pays out 3137.42% of its income as dividend. This is not a sustainable payout ratio.
DP3137.42%
EPS Next 2Y-68.82%
EPS Next 3YN/A
5.19
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.68%
Inst Owner Change-0.09%
Ins Owners40.17%
Ins Owner Change0%
Market Cap41.94M
Analysts82.86
Price Target8.67 (67.05%)
Short Float %0.21%
Short Ratio0.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 15.97% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP3137.42%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-350%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 259.5 | ||
| Fwd PE | N/A | ||
| P/S | 1.31 | ||
| P/FCF | 7.89 | ||
| P/OCF | 5.73 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.95 |
EPS(TTM)0.02
EY0.39%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.66
FCFY12.67%
OCF(TTM)0.91
OCFY17.46%
SpS3.97
BVpS-1.81
TBVpS-2.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.2% | ||
| ROE | N/A | ||
| ROCE | 9.43% | ||
| ROIC | 7.45% | ||
| ROICexc | 8.11% | ||
| ROICexgc | 8.75% | ||
| OM | 12.53% | ||
| PM (TTM) | 0.4% | ||
| GM | 75.79% | ||
| FCFM | 16.55% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexcg growth 3Y-17.95%
ROICexcg growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.59 | ||
| Debt/EBITDA | 1.7 | ||
| Cap/Depr | 234.65% | ||
| Cap/Sales | 6.26% | ||
| Interest Coverage | 1.99 | ||
| Cash Conversion | 150.07% | ||
| Profit Quality | 4125.62% | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 0.1 |
F-Score8
WACC10.6%
ROIC/WACC0.7
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.34%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year-1.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y266.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-15.93%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%